BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11302411)

  • 1. Etanercept in juvenile rheumatoid arthritis.
    Johnson CJ; Reilly KM; Murray KM
    Ann Pharmacother; 2001 Apr; 35(4):464-71. PubMed ID: 11302411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologic agents for the treatment of juvenile rheumatoid arthritis: current status.
    Carrasco R; Smith JA; Lovell D
    Paediatr Drugs; 2004; 6(3):137-46. PubMed ID: 15170361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etanercept therapy in children with juvenile rheumatoid arthritis.
    Hung JJ; Huang JL
    J Microbiol Immunol Infect; 2005 Dec; 38(6):444-6. PubMed ID: 16341346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current treatment of juvenile rheumatoid arthritis.
    Ilowite NT
    Pediatrics; 2002 Jan; 109(1):109-15. PubMed ID: 11773549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etanercept: efficacy and safety for approved indications.
    Kerensky TA; Gottlieb AB; Yaniv S; Au SC
    Expert Opin Drug Saf; 2012 Jan; 11(1):121-39. PubMed ID: 22074366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with etanercept for patients with juvenile rheumatoid arthritis in Taiwan--a preliminary report.
    Liang TC; Yang YH; Lin YT; Chiang BL
    J Microbiol Immunol Infect; 2005 Dec; 38(6):447-50. PubMed ID: 16341347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis.
    Lovell DJ; Reiff A; Jones OY; Schneider R; Nocton J; Stein LD; Gedalia A; Ilowite NT; Wallace CA; Whitmore JB; White B; Giannini EH;
    Arthritis Rheum; 2006 Jun; 54(6):1987-94. PubMed ID: 16732547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of once-weekly application of Etanercept in children with juvenile idiopathic arthritis.
    Kuemmerle-Deschner JB; Horneff G
    Rheumatol Int; 2007 Dec; 28(2):153-6. PubMed ID: 17641897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial.
    Lovell DJ; Giannini EH; Reiff A; Jones OY; Schneider R; Olson JC; Stein LD; Gedalia A; Ilowite NT; Wallace CA; Lange M; Finck BK; Burge DJ;
    Arthritis Rheum; 2003 Jan; 48(1):218-26. PubMed ID: 12528122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic use of etanercept in polyarticular course juvenile idiopathic arthritis over a two year period.
    Kietz DA; Pepmueller PH; Moore TL
    Ann Rheum Dis; 2002 Feb; 61(2):171-3. PubMed ID: 11796406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of etanercept in patients with the enthesitis-related arthritis category of juvenile idiopathic arthritis: results from a phase III randomized, double-blind study.
    Horneff G; Foeldvari I; Minden K; Trauzeddel R; Kümmerle-Deschner JB; Tenbrock K; Ganser G; Huppertz HI
    Arthritis Rheumatol; 2015 May; 67(8):2240-9. PubMed ID: 25891010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of diabetes mellitus during etanercept therapy in a child with systemic-onset juvenile rheumatoid arthritis.
    Bloom BJ
    Arthritis Rheum; 2000 Nov; 43(11):2606-8. PubMed ID: 11083287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of long-term etanercept in the treatment of methotrexate-refractory polyarticular-course juvenile idiopathic arthritis in Japan.
    Mori M; Takei S; Imagawa T; Imanaka H; Nerome Y; Higuchi R; Kawano Y; Yokota S; Sugiyama N; Yuasa H; Fletcher T; Wajdula JS
    Mod Rheumatol; 2012 Sep; 22(5):720-6. PubMed ID: 22212889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Juvenile idiopathic arthritis: therapies in the 21st century.
    Haines KA
    Bull NYU Hosp Jt Dis; 2007; 65(3):205-11. PubMed ID: 17922671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Switching the therapy from etanercept to infliximab in a child with rheumatoid factor positive polyarticular juvenile idiopathic arthritis.
    Nerome Y; Imanaka H; Nonaka Y; Takei S
    Mod Rheumatol; 2007; 17(6):526-8. PubMed ID: 18084710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of high dose etanercept in treatment of juvenile rheumatoid arthritis.
    Takei S; Groh D; Bernstein B; Shaham B; Gallagher K; Reiff A
    J Rheumatol; 2001 Jul; 28(7):1677-80. PubMed ID: 11469478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis.
    Lovell DJ; Reiff A; Ilowite NT; Wallace CA; Chon Y; Lin SL; Baumgartner SW; Giannini EH;
    Arthritis Rheum; 2008 May; 58(5):1496-504. PubMed ID: 18438876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etanercept improves active polyarticular juvenile rheumatoid arthritis.
    Martini A
    Clin Exp Rheumatol; 2001; 19(2):122-4. PubMed ID: 11326472
    [No Abstract]   [Full Text] [Related]  

  • 19. Etanercept (Enbrel) -- an update.
    Goffe B
    Skin Therapy Lett; 2004 Dec-2005 Jan; 9(10):1-4, 9. PubMed ID: 15657632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etanercept Immunex.
    Yung RL
    Curr Opin Investig Drugs; 2001 Feb; 2(2):216-21. PubMed ID: 11816834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.